Performance analysis of Lexicon Pharmaceuticals (LXRX)
Annual Return
Over the past 3 years, LXRX has had an average annual return of +4.06%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, LXRX has had an average annual return of -8.00%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, LXRX has had an average annual return of -17.39%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Apr 7, 2000, LXRX has had an average annual return of -14.20%, underperforming the benchmark SPY, which returned +8.13% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +102.27% | +57.14% | -52.14% | -19.86% | -51.33% | +14.94% | -17.41% | -37.55% | -32.80% | -28.56% | +3.94% | +109.07% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -49.43% | -18.66% | +71.37% | -10.42% | -15.33% | +21.42% | -53.77% | -16.05% | -1.13% | -52.93% | +31.68% | +24.49% |
| 2002 | 2001 | 2000 | |||||||||
| -59.01% | -30.60% | -11.31% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +27.27% | +6.25% | +3.36% | +34.96% | +10.24% | -2.73% | +102.27% | |||||
| 2025 | +3.57% | -8.62% | -33.96% | +60% | -14.29% | +50% | +13.89% | +2.44% | +22.62% | +1.94% | +3.81% | -19.27% | +57.14% |
| 2024 | +21.37% | +33.80% | -3.68% | -36.07% | +11.11% | -1.54% | +33.59% | -22.81% | -9.09% | +24.17% | -59.06% | -8.20% | -52.14% |
| 2023 | +17.12% | -0% | +8.19% | -1.62% | +37.91% | -30.68% | -12.07% | -14.38% | -36.64% | +13.25% | -13.83% | +44.44% | -19.86% |
| 2022 | -19.33% | -34.71% | +0.63% | -13.21% | -2.17% | +5.19% | +27.46% | +16.02% | -12.86% | -10.38% | -0.61% | -10.43% | -51.33% |
| 2021 | +131.03% | -9.12% | -18.43% | -17.23% | -9.73% | +4.79% | -22.86% | +33.33% | +1.67% | +10.11% | -13.40% | -14.04% | +14.94% |
| 2020 | -25.63% | -10.21% | -29.38% | -3.36% | +1.39% | +4.11% | -2.63% | -10.14% | -17.29% | -22.73% | +37.65% | +123.08% | -17.41% |
| 2019 | -28.85% | +12.50% | +4.69% | +4.25% | -7.24% | +16.83% | -78.50% | -1.94% | +126.73% | +23.58% | -4.95% | +17.47% | -37.55% |
| 2018 | +11.16% | -21.39% | -0.76% | -3.68% | +40.54% | +3.39% | -0.11% | -3.40% | -7.82% | -26.57% | +3.35% | -17.99% | -32.80% |
| 2017 | +3.61% | +11.90% | -10.56% | +8.78% | -11.27% | +18.77% | -0.88% | -7.09% | -18.89% | -17.09% | +0.39% | -3.34% | -28.56% |
Drawdown analysis of Lexicon Pharmaceuticals (LXRX)
The maximum drawdown for the LXRX was -99.91%, occurring on Mar 3, 2025. This drawdown has not yet recovered.
The current LXRX drawdown is -99.29%.
Since Apr 7, 2000 LXRX has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.91% | Jul 21, 2000 | 6189 | Mar 3, 2025 | Ongoing | Ongoing | Ongoing |
| -51.33% | Apr 7, 2000 | 13 | Apr 27, 2000 | 37 | Jun 20, 2000 | 50 |
| -15.33% | Jul 10, 2000 | 3 | Jul 13, 2000 | 5 | Jul 20, 2000 | 8 |
| -8.09% | Jun 21, 2000 | 1 | Jun 22, 2000 | 1 | Jun 23, 2000 | 2 |
| -5.17% | Jun 28, 2000 | 1 | Jun 29, 2000 | 3 | Jul 5, 2000 | 4 |